Get started
Author

Michael N. Youssef

Paraneoplastic syndromes in small cell lung cancer
2020 · Zaid Soomro, Michael Youssef, et al. · Journal of Thoracic Disease · 88
PDF
Trochleoplasty provides good clinical outcomes and an acceptable complication profile in both short and long-term follow-up
2018 · Laurie A. Hiemstra, Devin Peterson, et al. · Knee Surgery Sports Traumatology Arthroscopy · 75
EGFR ligand shifts the role of EGFR from oncogene to tumour suppressor in EGFR-amplified glioblastoma by suppressing invasion through BIN3 upregulation
2022 · Gao Guo, Ke Gong, et al. · Nature Cell Biology · 45
Convection enhanced delivery of Rhenium (186Re) Obisbemeda (186RNL) in recurrent glioma: a multicenter, single arm, phase 1 clinical trial
2025 · Andrew J. Brenner, Toral Patel, et al. · Nature Communications · 35
Surgery of malignant motor-eloquent gliomas guided by sodium-fluorescein and navigated transcranial magnetic stimulation: a novel technique to increase the maximal safe resection
2020 · Giovanni Raffa, Thomas Picht, et al. · Journal of Neurosurgical Sciences · 23
Impact of CDKN2A/B, MTAP, and TERT Genetic Alterations on Survival in IDH Wild Type Glioblastomas
2022 · Eric J. Hsu, Jamie Thomas, et al. · Discover Oncology · 21
PDF
Treatment strategies for glioblastoma in older patients: age is just a number
2019 · Michael Youssef, Ethan B. Ludmir, et al. · Journal of Neuro-Oncology · 18
Effect of health disparities on overall survival of patients with glioblastoma
2019 · Jacob J. Mandel, Michael Youssef, et al. · Journal of Neuro-Oncology · 15
Highlighting the need for reliable clinical trials in glioblastoma
2018 · Jacob J. Mandel, Michael Youssef, et al. · Expert Review of Anticancer Therapy · 13
Exploratory Evaluation of Personalized Ultrafractionated Stereotactic Adaptive Radiation Therapy (PULSAR) With Central Nervous System-Active Drugs in Brain Metastases Treatment
2024 · Michael Dohopolski, Luiza Giuliani Schmitt, et al. · International Journal of Radiation Oncology*Biology*Physics · 12
Neutrophilia and post-radiation thrombocytopenia predict for poor prognosis in radiation-treated glioma patients
2022 · Eric J. Hsu, Jamie Thomas, et al. · Frontiers in Oncology · 12
PDF
The HER2 flip-HER2 amplification of tumor cells in the cerebrospinal fluid of breast cancer patients with leptomeningeal disease: implications for treating the LM tumor with anti-HER2 therapy
2024 · Priya U. Kumthekar, Barbara Blouw, et al. · Frontiers in Oncology · 10
Distance traveled to glioblastoma treatment: A measure of the impact of socioeconomic status on survival
2021 · Cylaina E. Bird, Jeffrey I. Traylor, et al. · Clinical Neurology and Neurosurgery · 10
Recurrent Papillary Glioneuronal Tumor
2019 · Eric A. Goethe, Michael Youssef, et al. · World Neurosurgery · 9
A nationwide study of liver disease hospitalizations during the coronavirus pandemic in the United States
2023 · Mary Sedarous, Michael Youssef, et al. · Journal of Gastroenterology and Hepatology · 8
PDF
IDH mutation status and the development of venous thromboembolism in astrocytoma patients
2021 · Jacob J. Mandel, Michael Youssef, et al. · Journal of the Neurological Sciences · 8
Biom-05. the Her2 Flip: Her2 Amplification of Tumor Cells in the Cerebrospinal Fluid (csf-tcs) of Patients With Solid Tumor Leptomeningeal Metastasis
2022 · Priya Kumthekar, Michael Youssef, et al. · Neuro-Oncology · 6
Analysis of cerebrospinal fluid tumor-derived DNA to obviate biopsy of IDH-mutant brainstem glioma in an adult
2025 · Michael Youssef, Alexandra Larson, et al. · The Journal of Liquid Biopsy · 5
PDF
Key Themes in the Care of Inflammatory Bowel Diseases Among Immigrant Populations: A Systematic Review
2025 · Michael Youssef, Parul Tandon, et al. · Digestive Diseases and Sciences · 5
Longitudinal CSF Tumor Cell Enumeration and Mutational Analysis as a Driver for Leptomeningeal Disease Management
2025 · Arushi Tripathy, Pericles Corkos, et al. · Cancers · 4
Ltbk-02. Evaluation of Paxalisib in Gbm Agile Phase 3 Registration Platform Trial for Newly Diagnosed and Recurrent Glioblastoma
2024 · Ingo K Mellinghoff, Timothy Cloughesy, et al. · Neuro-Oncology · 4
PDF
Lmap-21 Preliminary Clinical Data in the Phase 1/2a Dose Escalation Trial of Rhenium (186re) Obisbemeda (186rnl) in Leptomeningeal Metastases (lm): the Respect-lm Trial
2023 · Michael Youssef, Ande Bao, et al. · Neuro-Oncology Advances · 4
PDF
Does curve magnitude in adolescent idiopathic scoliosis (AIS) affect frequency and quality of sport participation? A feasibility study
2021 · Michael Youssef, John Soliman, et al. · Pilot and Feasibility Studies · 4
PDF
Comparative Outcomes of Standard Radiation Therapy and 5-Fraction Adaptive Stereotactic Radiation Therapy in Newly Diagnosed Glioblastoma: A Propensity Score–Matched Analysis
2025 · Michael Dohopolski, Luiza Giuliani Schmitt, et al. · Advances in Radiation Oncology · 3
Tips-23 Safety and Feasibility Results From a Phase 1/2 Clinical Trial of Rhenium (186re) Obisbemeda (186rnl) in Recurrent Glioma: the Respect-gbm Trial
2023 · Andrew Brenner, Toral Patel, et al. · Neuro-Oncology Advances · 3
PDF
Works count: 87
Citation count: 467
H-index: 11
I10-index: 13
Year
Topic
Type